The present study describes a case of severe pulmonary arterial hypertension (PAH) associated with unilateral lung destruction due to bronchiectasis in a patient with common variable immunodeficiency (CVID). Initially, the patient's treatment included antibiotics, oral anticoagulants, diuretics, and immunoglobulin replacement therapy. However, the patient's condition improved significantly only after inhaled iloprost was administered. Three months later, his PAH was almost reversed. The hemodynamic response of our patient suggests that inhaled iloprost may have a role in the treatment of sustained PAH related to unilateral lung destruction. (c) 2007 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved
Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstruc...
Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstruc...
Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost trea...
Abstract Case Pulmonary hypertension secondary to respiratory disease most often occurs as a complic...
The present report describes a patient with common variable immunodeficiency who suffered severe pul...
Portopulmonary hypertension (PoPH) is a serious condition without an established treatment. Drugs us...
SummaryNebulised iloprost is established therapy of severe pulmonary hypertension; however, the effe...
Inhaled iloprost efficiently improves pulmonary hemodynamics, exercise capacity, and quality of life...
Background: The majority of patients with idiopathic pulmonary arterial hypertension (IPAH) in funct...
AIMS: To investigate the long-term safety of inhaled iloprost in patients with pulmonary hypertensio...
ABSTRACT: The present study describes a case of pulmonary arterial hypertension (PAH) associated wit...
The aim of this study was to confirm the utility of aerosolised iloprost for identifying long-term r...
Primary pulmonary hypertension is a rare disease in childhood associated with a poor prognosis. Howe...
Inhaled prostacyclin analogue iloprost is currently utilized in adult patients with pulmonary arteri...
AbstractBackground and objectivesBecause there is no cure for idiopathic pulmonary artery hypertensi...
Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstruc...
Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstruc...
Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost trea...
Abstract Case Pulmonary hypertension secondary to respiratory disease most often occurs as a complic...
The present report describes a patient with common variable immunodeficiency who suffered severe pul...
Portopulmonary hypertension (PoPH) is a serious condition without an established treatment. Drugs us...
SummaryNebulised iloprost is established therapy of severe pulmonary hypertension; however, the effe...
Inhaled iloprost efficiently improves pulmonary hemodynamics, exercise capacity, and quality of life...
Background: The majority of patients with idiopathic pulmonary arterial hypertension (IPAH) in funct...
AIMS: To investigate the long-term safety of inhaled iloprost in patients with pulmonary hypertensio...
ABSTRACT: The present study describes a case of pulmonary arterial hypertension (PAH) associated wit...
The aim of this study was to confirm the utility of aerosolised iloprost for identifying long-term r...
Primary pulmonary hypertension is a rare disease in childhood associated with a poor prognosis. Howe...
Inhaled prostacyclin analogue iloprost is currently utilized in adult patients with pulmonary arteri...
AbstractBackground and objectivesBecause there is no cure for idiopathic pulmonary artery hypertensi...
Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstruc...
Inhaled iloprost potentially improves hemodynamics and gas exchange in patients with chronic obstruc...
Objective: To evaluate clinical efficacy, safety and tolerability of long-term inhaled iloprost trea...